GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.880
+0.590 (25.76%)
At close: Sep 4, 2026, 4:00 PM EDT
2.584
-0.296 (-10.28%)
After-hours: Sep 4, 2026, 7:59 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $6.3 million as of September 4, 2026. Its market cap has increased by 71.44% in one year.
Market Cap
6.30M
Enterprise Value
-4.61M
1-Year Change
71.44%
Ranking
Category
Stock Price
$2.88
ChartMarket Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $6.30M, a decrease of -75.10%. That is a compound annual growth rate of -33.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 6.30M | 152.05% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 5.73M |
| Kairos Pharma | 5.65M |
| Cardio Diagnostics Holdings | 5.42M |
| PharmaCyte Biotech | 5.27M |
| HCW Biologics | 5.27M |
| Can-Fite BioPharma | 5.20M |
| Liminatus Pharma | 4.97M |
| Pulmatrix | 4.97M |